Phase I Open-Label, Dose Escalation And Expansion Study Of Yh003, An Anti-Cd40 Agonist Monoclonal Antibody In Combination With Toripalimab In Patients (Pts) With Advanced Solid Tumours.
Toripalimab;YH-003
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I Open-Label, Dose Escalation And Expansion Study Of Yh003, An Anti-Cd40 Agonist Monoclonal Antibody In Combination With Toripalimab In Patients (Pts) With Advanced Solid Tumours. ### Output: Toripalimab;YH-003